Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease

BACKGROUND/AIMS: The influences of Helicobacter pylori eradication therapy on the disease course of inflammatory bowel disease (IBD) are still unclear. We therefore conducted a multicenter, retrospective cohort study to evaluate the safety of H. pylori eradication therapy for IBD patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinzaki, Shinichiro, Fujii, Toshimitsu, Bamba, Shigeki, Ogawa, Maiko, Kobayashi, Taku, Oshita, Masahide, Tanaka, Hiroki, Ozeki, Keiji, Takahashi, Sakuma, Kitamoto, Hiroki, Kani, Kazuhito, Nanjo, Sohachi, Sugaya, Takeshi, Sakakibara, Yuko, Inokuchi, Toshihiro, Kakimoto, Kazuki, Yamada, Akihiro, Yasuhara, Hisae, Yokoyama, Yoko, Yoshino, Takuya, Matsui, Akira, Nakamura, Misaki, Tomizawa, Taku, Sakemi, Ryosuke, Kamata, Noriko, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223447/
https://www.ncbi.nlm.nih.gov/pubmed/30301329
http://dx.doi.org/10.5217/ir.2018.00044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223447/
https://www.ncbi.nlm.nih.gov/pubmed/30301329
http://dx.doi.org/10.5217/ir.2018.00044

Ejemplares similares